Inositols and Metabolic Syndrome: What You Should Know

#SYSTEMPHARM #UKRAINE

Metabolic disorders can affect the functioning of various body systems. One such condition is metabolic syndrome, which is associated with an increased risk of developing type 2 diabetes and cardiovascular diseases.
In this context, particular attention is given to inositols — naturally occurring compounds involved in important processes in the body, including insulin function and glucose metabolism. Let’s take a closer look at metabolic syndrome, why inositols are being studied in this area, and what role they play in the body.
What Is Metabolic Syndrome?
Metabolic syndrome is a combination of several metabolic disorders that often occur together. These include:
increased waist circumference (abdominal obesity);
elevated blood glucose levels;
high blood pressure;
elevated triglyceride levels;
low levels of high-density lipoprotein (HDL), often referred to as “good” cholesterol.
The presence of three or more of these factors may indicate metabolic syndrome. A diagnosis is made by a healthcare professional based on relevant measurements and medical examinations.
Why does this matter? Because the combination of these conditions increases the risk of developing other diseases and may negatively affect long-term health.
Which Health Conditions Are Associated with Metabolic Syndrome?
Metabolic syndrome is most commonly associated with the following conditions:
Type 2 diabetes. Reduced insulin sensitivity and elevated blood glucose levels can contribute to the development of this disease.
Metabolic dysfunction-associated steatotic liver disease (MASLD). Previously known as non-alcoholic fatty liver disease (NAFLD), this condition is characterized by fat accumulation in liver cells. It is often associated with excess body weight, insulin resistance, and other metabolic disorders.
Atherosclerosis and coronary heart disease. High blood pressure, changes in blood lipid levels, and impaired glucose metabolism increase the risk of vascular damage and cardiovascular disease.
Stroke. Metabolic disorders can increase the risk of vascular complications, including stroke.
Polycystic ovary syndrome (PCOS). Women with PCOS often experience insulin resistance, which may be accompanied by metabolic disturbances.
It is important to understand that these conditions are not obligatory components of metabolic syndrome. However, they may be associated with the same underlying metabolic disorders.
What Are Inositols and What Do They Do in the Body?
Inositols are naturally occurring compounds found in the human body and also obtained from food. They are involved in cellular function and communication between cells.
Among the different forms of inositol, two have been studied most extensively:
Myo-inositol — involved in cellular processes, including those related to insulin activity.
D-chiro-inositol — also plays a role in insulin signalling and metabolic processes.
Insulin helps cells absorb glucose and use it to produce energy. This is why inositols attract the attention of researchers studying insulin resistance and metabolic disorders.
Why Are Inositols Being Studied in Metabolic Syndrome?
Interest in inositols is primarily related to their involvement in processes that regulate glucose metabolism and the body’s sensitivity to insulin.
Scientific studies are investigating whether additional intake of myo-inositol and D-chiro-inositol can affect certain metabolic markers, including insulin, blood glucose, and lipid levels.
Some studies suggest that inositols may have beneficial effects on certain of these markers. However, results vary between studies, and the current body of evidence has some limitations.
Another area of research is polycystic ovary syndrome (PCOS). International guidelines allow inositol to be considered for women with PCOS, depending on their individual needs. However, they also point out that there is currently insufficient evidence of its clinical effectiveness to recommend specific forms or amounts.
Thus, inositols remain an area of scientific interest in metabolic and reproductive health, but they are not a standalone treatment for metabolic syndrome.
Myo-Inositol and D-Chiro-Inositol in DuoMio
DuoMio combines two forms of inositol: myo-inositol (2,000 mg) and D-chiro-inositol (50 mg), in a 40:1 ratio.
The formula is complemented by L-glutathione (50 mg) and Quatrefolic® (760 mcg, equivalent to 400 mcg of folic acid).
This combination of ingredients is part of a formula designed to support reproductive health in both women and men.
At the same time, it is important not to confuse the role of inositols in metabolic processes with a therapeutic effect of a dietary supplement. DuoMio is not intended to treat metabolic syndrome, diabetes, or any other disease.
A Comprehensive Approach to Metabolic Health
Metabolic syndrome requires attention to overall health. Important measures include a balanced diet, regular physical activity, monitoring blood pressure, blood glucose and cholesterol levels, and consulting a healthcare professional when needed.
Inositols continue to be studied because of their involvement in processes related to insulin function and metabolism. However, additional intake of these compounds does not replace medical advice, prescribed treatment, or lifestyle changes.
Taking an informed approach to metabolic health starts with understanding how the body works, identifying potential disorders in a timely manner, and taking a comprehensive approach to personal well-being.